Table 4.

Endoscopic response and remission rates at week 6 and week 14 post vedolizumab administration.

	Post vedolizumab administration
	Week 6	Week 14
Number of patients with a valid Mayo endoscopic subscore among those with a baseline Mayo endoscopic subscore ⩾ 2	9	57
Endoscopic response rate, n (%)	2 (22.2)	28 (49.1)
Endoscopic remission rate, n (%)	2 (22.2)	28 (49.1)
Complete endoscopic remission rate, n (%)	0 (0)	4 (7.0)

Endoscopic response was defined as a decrease of at least 50% from baseline Mayo endoscopic subscore. Endoscopic remission was defined as Mayo endoscopic subscore of 0–1. Complete endoscopic remission was defined as Mayo endoscopic subscore of 0.